Seeking to cure the incurable – Canada and Japan setting the world pace for innovations in regenerative medicine

Written by Lee Buckler

National Post article highlights the important role the Centre for Commercialization of Regenerative Medicine (CCRM) is taking to help Canadian cell therapy companies like RepliCel Life Sciences (TSX.V: RP) create pathways for commercialization in Canada and Japan.

Click here to read the full article on the Financial Post website.